Talk of The Villages Florida - Rentals, Entertainment & More
Talk of The Villages Florida - Rentals, Entertainment & More
#46
|
||
|
||
Quote:
I trust the two medical doctors who post on this forum; Blueash and Soaring Eagles and I trust many posters who carefully use disclaimers and qualifiers and choose to quote well documented sources usually held to be reliable by the general public and English teachers. . Goodlife. Please tell us what you did for gainful employment before you retired?
__________________
It is better to laugh than to cry. |
|
#47
|
||
|
||
Quote:
I like to have a plan. This virus can go from mild symptoms to killing you in a few days. |
#48
|
||
|
||
Quote:
PS I am not giving medical advice, merely reporting news about Doctors using various drug therapies for coronavirus. Last edited by GoodLife; 04-27-2020 at 06:39 PM. |
#49
|
||
|
||
Quote:
1. A large portion of the media likes to bash a certain someone. 2. Pharmaceutical and medical companies spend more on lobbying than any other industry. 3. HCQ pills have no patent and cost dollars per day while designer drugs like remdesivir more like $1000 per day. 4. It's a fact that there is fraud of many types in scientific and medical research, certainly not all of it but to deny it exists would be foolish. I post about many things, not just HCQ. For instance I warned people about how virus particles from sneezes and coughs can travel more than 6 feet, and the original CDC advisory on no need to be wearing masks might be a mistake. I get lots of "thanks" for my posts, you are entitled to your opinion of course. |
#50
|
||
|
||
COVID-19 MANAGEMENT PROTOCOL Developed and updated by Paul Marik, MD Chief of Pulmonary and Critical Care Medicine Eastern Virginia Medical School, Norfolk, VA
Preliminary data suggests that chloroquine and hydroxychloroquine decrease the duration of viral shedding. In addition, chloroquine has favorable immunomodulating properties including inhibition of PAI-1 expression. These agents are now FDA approved for the treatment of COVID19. These agents (if available) could be used to mitigate/curtail the spread of this virus and could be used in elderly patients with comorbidities at risk of progression and death. Zinc (Zn++) inhibits viral RNA dependent RNA polymerase (replicase). Chloroquine and hydroxychloroquine are potent Zn ionophores that increase intracellular Zn concentrations https://www.inciid.org/sites/default...20-revised.pdf |
#51
|
||
|
||
Yes, I tend to "trot out" recognized experts.
In terms of credibility, Dr. Raoult is one of the world’s most eminent scientists. “According to the Thomson Reuters source “Highly Cited Researchers List”, Raoult is among the most influential researchers in his field and his publications are among the 1% most consulted in academic journals. He is one of the 99 most cited microbiologists in the world and one of the 73 most highly cited French scientists. He is a world reference for Q fever and Whipple’s disease. In April 2017, on Google Scholar citations, he cumulated over 104,000 citations and an h index of 148. He is also on the list of the 400 most cited authors in the biomedical world…” |
#52
|
||
|
||
The VA study is even worse than I thought. They moved patients from control group to HCQ group once they went on ventilator! This garbage will get savaged in peer review.
The conclusion that HC causes higher risk of death is basically wrong due to a huge sampling bias. The problem lies in the fact that once people went on ventilators they were given HC or HC+AZ. This re-categorised the patients by increasing the number of high risk patients in the HC and HC+AZ groups making the No HC an invalid control group. Before ventilation the statistics was like this: (Table 4 in paper) HC: 90 - 9 (10.0%) deaths - 69 (76.6%) recover - 12 (13.3%) onto ventilation HC+AZ: 101 - 11 (10.9%) deaths - 83 (82.2%) recover - 7 (06.9%) onto ventilation No HC: 177 - 15 ( 8.4%) deaths - 137 (77.4%) recover - 25 (14.1%) onto ventilation We see that death-rate is about the same for all groups but HC+AZ seams to have the highest recovery rate but it might not be statistically significant. Now once people hit ventilation the re-categorisation occurs. More patients where given HC and HC+AZ which moved them from the No HC group to the HC or HC+AZ group. These groups therefore have a much higher % of ventilation patients because they were given the drugs after they hit ventilation. The following data can be derived from the paper but is not presented: Once people hit ventilation we have the following results. HC: 19 - 18 (95%) deaths - 1 (11%) recover HC+AZ: 19 - 14 (73%) deaths - 5 (27%) recover No HC: 6 - 3 (50%) deaths - 3 (50%) recover If you compare these 2 tables, you see that 25 patient with No HC reach ventilation. Once they reach ventilation, 19 of these where give HC or HC+AZ, thereby moved from the No HC group to the other two. 79.5% of all patients reaching ventilation died so arguably 14 patients that died where moved from the No HC group to the other 2 groups only once they reach the much higher risk state. Here are the number of people per group that got ventilation: HC: 97 - 19 (19.6%) got ventilation HC+AZ: 113 - 19 (16.8%) got ventilation No HC: 158 - 6 ( 3.4%) got ventilation So the conclusion that HC causes more death is basically wrong. All it shows is that people that need ventilation are more likely to die. Last edited by GoodLife; 04-28-2020 at 07:13 PM. |
Closed Thread |
|
|